Reduced-intensity conditioning allogeneic stem cell transplantation for patients with chemoresistant or relapsed follicular lymphoma [1]

British Journal of Haematology

Volumn 135, Issue 3, 2006, Pages 408-410

  De Lavallade, Hugues ^a   Mohty, Mohamad ^a,b,c   El Cheikh, Jean ^a   Cassier, Philippe A ^a   Faucher, Catherine ^a   Fürst, Sabine ^a   Vey, Norbert ^a   Stoppa, Anne Marie ^a   Sainty, Daniele ^a,b   Arnoulet, Christine ^a   Xerri, Luc ^a,b   Gastaut, Jean Albert ^a,b   Blaise, Didier ^a,b,c   Bouabdallah, Reda ^a  

^a INSTITUT PAOLI CALMETTES   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c INSERM   (France)

Author keywords

Follicular lymphoma; Graft versus lymphoma effect; Reduced intensity conditioning

Indexed keywords

ALPHA INTERFERON; BLEOMYCIN; BUSULFAN; CHLORAMBUCIL; CHLORAMPHENICOL; CISPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; FOLINIC ACID; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; RITUXIMAB; THYMOCYTE ANTIBODY; VINCRISTINE;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER RESISTANCE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLICULAR LYMPHOMA; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LYMPHOCYTE TRANSFER; MALE; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING;

ADULT; DRUG RESISTANCE, NEOPLASM; FEMALE; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; RECURRENCE; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 33749244287     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06308.x     Document Type: Letter

References (6)

1. van Besien, K., Loberiza, Jr, F.R., Bajorunaite, R., Armitage, J.O., Bashey, A., Burns, L.J., Freytes, C.O., Gibson, J., Horowitz, M.M., Inwards, D.J., Marks, D.I., Martino, R., Maziarz, R.T., Molina, A., Pavlovsky, S., Pecora, A.L., Schouten, H.C., Shea, T.C., Lazarus, H.M., Rizzo, J.D. & Vose, J.M. (2003) Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma. Blood, 102, 3521-3529.
2. Bierman, P.J., Sweetenham, J.W., Loberiza, Jr, F.R., Taghipour, G., Lazarus, H.M., Rizzo, J.D., Schmitz, N., van Besien, K., Vose, J.M., Horowitz, M. & Goldstone, A. (2003) Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation-The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Journal of Clinical Oncology, 21, 3744-3753.
3. Faulkner, R.D., Craddock, C., Byrne, J.L., Mahendra, P., Haynes, A.P., Prentice, H.G., Potter, M., Pagliuca, A., Ho, A., Devereux, S., McQuaker, G., Mufti, G., Yin, J.L. & Russell, N.H. (2004) BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients. Blood, 103, 428-434.
4. Khouri, I.F., Saliba, R.M., Giralt, S.A., Lee, M.S., Okoroji, G.J., Hagemeister, F.B., Korbling, M., Younes, A., Ippoliti, C., Gajewski, J.L., McLaughlin, P., Anderlini, P., Donato, M.L., Cabanillas, F.F. & Champlin, R.E. (2001) Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality. Blood, 98, 3595-3599.
5. Marks, D.I., Lush, R., Cavenagh, J., Milligan, D.W., Schey, S., Parker, A., Clark, F.J., Hunt, L., Yin, J., Fuller, S., Vandenberghe, E., Marsh, J., Littlewood, T., Smith, G.M., Culligan, D., Hunter, A., Chopra, R., Davies, A., Towlson, K. & Williams, C.D. (2002) The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation. Blood, 100, 3108-3114.
6. Peniket, A.J., Ruiz de Elvira, M.C., Taghipour, G., Cordonnier, C., Gluckman, E., de Witte, T., Santini, G., Blaise, D., Greinix, H., Ferrant, A., Cornelissen, J., Schmitz, N. & Goldstone, A.H. (2003) An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation. Bone Marrow Transplantation, 31, 667-678.